Substituted benzoxazole-benzthiazole-2-thiones: interrelationship between anticonvulsant activity and inhibition of nicotinamide adenine dinucleotide-dependent oxidations and monoamine oxidase.
D062365:Aminobenzoates / Q000494:pharmacology; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001583:Benzoxazoles / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D066298:In Vitro Techniques; D007523:Isocitrates / Q000378:metabolism; D007656:Ketoglutaric Acids / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009243:NAD / Q000037:antagonists & inhibitors*; D010084:Oxidation-Reduction; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D011773:Pyruvates / Q000378:metabolism; D051381:Rats; D012640:Seizures / Q000139:chemically induced; D013050:Spectrometry, Fluorescence; D013386:Succinates / Q000378:metabolism; D013844:Thiazoles / Q000494:pharmacology*; D013871:Thiones / Q000494:pharmacology
D062365:Aminobenzoates; D000927:Anticonvulsants; D001583:Benzoxazoles; D007523:Isocitrates; D007656:Ketoglutaric Acids; D008996:Monoamine Oxidase Inhibitors; D011773:Pyruvates; D013386:Succinates; D013844:Thiazoles; D013871:Thiones; D009243:NAD; D010433:Pentylenetetrazole